Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis
Clinical trial NCT06284265 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06284265
- Sponsor
- Materia Medica Holding
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2026-12-31
- Enrollment
- 415
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.